论文部分内容阅读
目的:分析短肽型肠内营养剂在重症监护室患者的应用效果。方法:选取我院2011年12月-2012年12月间收治的60名重症监护室患者作为研究对象,随机分为观察组与对照组,每组患者各30例。对照组患者采用普通肠内营养支持,观察组患者给予短肽型肠内营养剂,对两组患者营养支持前后人血清总蛋白、淋巴细胞计数、白蛋白、血红蛋白、前白蛋白指标变化以及胃肠道功能状况进行分析对比。结果:营养支持前两组患者的各指标比较无明显差异(P>0.05),营养支持后两组患者的各指标比较差异具有明显差异(P<0.05)。对比两组患者的胃肠道功能障碍情况发现,观察组患者的胃肠道不良反应(胃潴留、上消化道出血、反流、腹泻)发生率明显低于对照组,两组数据结果比较具有明显差异(P<0.05)。结论:短肽型肠内营养剂在重症监护室患者具有良好的应用效果,能促进患者的营养恢复正常水平,并降低胃肠道不良反应,值得在临床应用上推广。
Objective: To analyze the effect of short peptide enteral nutrition in intensive care unit patients. Methods: Sixty ICU patients from December 2011 to December 2012 in our hospital were selected as study subjects and randomly divided into observation group and control group, with 30 patients in each group. Patients in the control group were treated with ordinary enteral nutrition and patients in the observation group were treated with short peptide enteral nutrition. The changes of total serum protein, lymphocyte count, albumin, hemoglobin, prealbumin index before and after nutrition support in both groups, Intestinal function status analysis and comparison. Results: There was no significant difference (P> 0.05) between the two groups before nutritional support, and there was significant difference between the two groups after nutrition support (P <0.05). Comparing the two groups of patients with gastrointestinal dysfunction found that the observation group of patients with gastrointestinal adverse reactions (gastric retention, upper gastrointestinal bleeding, reflux, diarrhea) was significantly lower than the incidence of the control group, the two data results compared with Significant difference (P <0.05). Conclusion: Peptide enteral nutrition in patients with intensive care unit has a good effect, can promote patients with normal levels of nutritional recovery and reduce gastrointestinal adverse reactions, it is worth promoting in clinical application.